U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885424) titled 'A Long-Term Follow-Up Study of Participants Treated with A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products' on March 12.
Brief Summary: This protocol is to ensure consistent long-term follow-up for delayed safety events in participants who received A2 Bio gene therapy (GT) products.
Study Start Date: Aug. 31, 2025
Study Type: OBSERVATIONAL
Condition:
Solid Tumor Cancer
Solid Tumor, Unspecified, Adult
Colorectal Carcinoma
Colorectal Carcinoma (CRC)
Non Small Cell Lung Cancer
Small Cell Lung Cancer ( SCLC )
Pancreatic Cancer
NSCLC
Mesothelioma
Ovarian Cancer
Ovarian Carcinoma
Head and Neck (HNSCC)
Head and Neck Cancer
Renal ...